ArticleBMC infectious diseases2025
Antimicrobial susceptibility patterns and associated risk factors of bacterial isolate among urinary tract infection suspected patients at University of Gondar Comprehensive Specialized Hospital North west Ethiopia.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUrinary tract infections (UTIs) are the most common infections affecting millions of people worldwide. There is a shortage of comprehensive data addressing the current prevalence, antimicrobial susceptibility pattern, and associated risk factors in clinically suspected UTI patients.
objectiveTo assess the prevalence, bacterial profile, antimicrobial susceptibility pattern and associated risk factors for urinary tract infection among clinically suspected patients.
methodA hospital-based cross-sectional study was conducted from May 1, 2023, to November 30, 2023, in patients clinically suspected of having a UTI. Sociodemographic and clinical data were collected using structured questionnaires. A total of 320 patients were enrolled, and a systematic random sampling technique was used to select the studyparticipantsApproximately 5 to 10 ml of morning midstream urine was collected and inoculated primarily on the CLED agar. Thereafter, the isolates were subculture on Blood agar and MacConkey media for identification. The Kirby-Bauer disc diffusion method was used to determine the antibiotic susceptibility pattern of the isolates. Extended-spectrum beta-lactamase and carbapenemase-producing strains were detected using combined disk and modified carbapenem inhibition test methods, respectively. The data were entered and analyzed using SPSS version 27 software. A p value < 0.05 was considered to indicate statistical significance.
resultsOf the total participants, 212 (66.25%) were females. The mean age of the participants was 35.99 ± 17.17 years. The prevalence of UTIs was 21.9%. A total of 70 different bacterial isolates were recovered. Of these, 58 (82.9%) and 12 (17.1%) were gram-negative and gram-positive bacterial isolates, respectively. Among the gram-negative bacteria,E.coli isoltes was 34 (58.6%) predominant, followed by K. pneumoniae 22 (37.9%) and P. mirabilis 2 (3.5%), while S. aureus 9 (75%) was prevalent among the gram-positive isolates. Meropenem and nitrofurantoin are effective antibiotics against gram-negative bacteria.The prevalence of multidrug resistance was 71.4%. Approximately 27 (46.6%) and 4 (6.9%) gram-negative isolates were found to be extended-spectrum beta-lactamases and carbapenemase producers, respectively. A history of UTI, catheterization, HIV, and diabetes were independent risk factors associated with UTI (p < 0.05).
conclusionThe prevalence of UTIs among clinically suspected patients was high, with increased positivity rates for MDR, ESBL and CP-producing strains. Patients with UTI should have a critical need for appropriate antimicrobial administration and the practice of providing patients with suitable antibioticsAntibiotic should be prescribed based on results obtained from the laboratory diagnosis of AST and complying with local guidelines by considering the most often domestically isolated organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.